Success Metrics

Clinical Success Rate
82.3%

Based on 65 completed trials

Completion Rate
82%(65/79)
Active Trials
14(12%)
Results Posted
14%(9 trials)
Terminated
14(12%)

Phase Distribution

Ph early_phase_1
3
3%
Ph phase_1
14
12%
Ph phase_2
21
18%
Ph phase_4
32
28%
Ph not_applicable
30
26%
Ph phase_3
13
11%

Phase Distribution

17

Early Stage

21

Mid Stage

45

Late Stage

Phase Distribution113 total trials
Early Phase 1First-in-human
3(2.7%)
Phase 1Safety & dosage
14(12.4%)
Phase 2Efficacy & side effects
21(18.6%)
Phase 3Large-scale testing
13(11.5%)
Phase 4Post-market surveillance
32(28.3%)
N/ANon-phased studies
30(26.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.2%

65 of 81 finished

Non-Completion Rate

19.8%

16 ended early

Currently Active

14

trials recruiting

Total Trials

114

all time

Status Distribution
Active(18)
Completed(65)
Terminated(16)
Other(15)

Detailed Status

Completed65
Terminated14
unknown14
Recruiting11
Active, not recruiting3
Not yet recruiting3

Development Timeline

Analytics

Development Status

Total Trials
114
Active
14
Success Rate
82.3%
Most Advanced
Phase 4

Trials by Phase

Early Phase 13 (2.7%)
Phase 114 (12.4%)
Phase 221 (18.6%)
Phase 313 (11.5%)
Phase 432 (28.3%)
N/A30 (26.5%)

Trials by Status

terminated1412%
withdrawn22%
enrolling_by_invitation11%
active_not_recruiting33%
suspended11%
unknown1412%
completed6557%
recruiting1110%
not_yet_recruiting33%

Recent Activity

Clinical Trials (114)

Showing 20 of 114 trialsScroll for more
NCT05025293Phase 4

Zoledronate Early to Hip Fracture Patients - Safe and Effective?

Completed
NCT05091242Phase 2

The PREVENT AGITATION Trial II - Children ≤1 Year

Recruiting
NCT06305182Phase 2

Metreleptin in Anorexia Nervosa

Recruiting
NCT07449403Not Applicable

SII Levels Following PENG Block in Hip Arthroplasty

Recruiting
NCT07449442Not Applicable

SII Levels Following iPACK Block With Adductor Canal Block in Knee Arthroplasty

Recruiting
NCT06778421Phase 1

Impact of OnabotulinumtoxinA (BOTOX®) on Stress

Completed
NCT04913649Phase 4

Intravenous Iron to Treat Postoperative Anemia in Older Cardiac Surgery Patients

Recruiting
NCT07423910Not Applicable

PRO-RSTAP: Effect of TAP and RS Blocks on Recovery After Inguinal Hernia Surgery (PRO-RSTAP)

Recruiting
NCT05564130Phase 4

Bicarbonate for In-Hospital Cardiac Arrest

Active Not Recruiting
NCT05147909Not Applicable

Impact of Dietary Phosphate Excess on Exercise Capacity and Visceral Adiposity

Recruiting
NCT05056220Phase 3

Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites

Recruiting
NCT06300229Phase 1

NAPO - Novel Approach for Oligospermia

Completed
NCT06872060Not Applicable

The Effects of Glucagon on Renal Regional Blood Flow in Humans Measured by Magnetic Resonance.

Not Yet Recruiting
NCT06622187Phase 4

Bleeding Prevention With Desmopressin for Allograft Kidney Biopsies

Enrolling By Invitation
NCT06917482Phase 1

A Study to Assess the Safety and Effects of the Investigational Drug BW-40202 in Healthy Volunteers

Recruiting
NCT07055087Phase 2

Prevent Cognitive Decline in GBA-associated Parkinson's Disease

Not Yet Recruiting
NCT01692002Not Applicable

Oral Propionate to Treat and Prevent Diabetes

Terminated
NCT00639912Phase 4

Effects of Hydration to Prevent Contrast Induced Nephropathy in PCI for ST-elevation Myocardial Infarction.

Completed
NCT06968182Not Applicable

The Effect of Sodium on Erythrocyte Salt Sensitivity, Syndecan-1 and Heparin Sulfate in Healthy Subjects.

Completed
NCT04717336Not Applicable

Genomics, Environmental Factors and Social Determinants of Cardiovascular Disease in African Americans Study (GENE-FORECAST): Sodium Intervention Trial (SIT)

Completed

Drug Details

Intervention Type
DRUG
Total Trials
114